FDA Import Refusal 799-4248242-0/11/1 — Glaxo Wellcome S.A.

Glaxo Wellcome S.A. — FEI 3004195227

The FDA refused shipment 799-4248242-0/11/1 from Glaxo Wellcome S.A. (Spain) on Jan 31, 2018. The refused product falls under Drugs and Biologics — AZELASTINE HYDROCHLORIDE/FLUTICASONE, ANTI-HISTAMINE STEROID (ANTI-HISTAMINIC). Cited charge: 75 This firm has 5 or more other import refusals on record.